Skip to main content

Table 5 The effect of Matrix Model treatment and MPH on METH Positive Urine test (MPUT) 1

From: The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder

Variable

Group

Baseline

Week 3

Week 6

Week 9

Week 12

P-value*

OR (95% CI)

MPUT

Matrix (n = 20)

20 (100)

19 (95)

18 (90)

16 (80)

16 (80)a

< 0.001

2.59 (0.87–7.75)

Methylphenidate (n = 22)

22 (100)

20 (90.9)

18 (81.8)

16 (72.7)

13 (59.1)

4.95 (1.79–13.68)

Matrix combination with methylphenidate (n = 21)

21 (100)

19 (90.5)

17 (81)

12 (57.1)

8 (38.1)

7.63 (2.82–20.67)

Control (n = 22)

22 (100)

21 (95.5)

21 (95.5)

20 (90.9)

21 (95.5)b

Reference

  1. 1 All variables are presented as number (%)
  2. * GEE analysis (generalized estimating equations)
  3. a: Significant difference between Matrix and Matrix combination with methylphenidate groups
  4. b: Significant difference between Control with Methylphenidate and Matrix combination with methylphenidate groups